In patients with Duchenne muscular dystrophy (DMD), the direct effect of the characteristic lack of dystrophin is the loss of muscle sarcolemma membrane stability, which results in DMD pathology (Mozzetta et al., 2024). This evidence concerns the gene DMD and Duchenne muscular dystrophy.